Application of cardiac magnetic resonance imaging in cardiomyopathy

Current Heart Failure Reports

Volumn 5, Issue 3, 2008, Pages 128-135

  Steel, Kevin E ^a   Kwong, Raymond Y ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM CHELATE;

CARDIAC GRAFT REJECTION; CARDIAC MAGNETIC RESONANCE IMAGING; CARDIOMYOPATHY; CONGESTIVE CARDIOMYOPATHY; CONTRAST ENHANCEMENT; DIAGNOSTIC VALUE; HEART AMYLOIDOSIS; HEART RIGHT VENTRICLE DYSPLASIA; HEART SARCOIDOSIS; HEART TRANSPLANTATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMAGE ANALYSIS; IRON OVERLOAD; ISCHEMIC HEART DISEASE; LEFT VENTRICULAR NONCOMPACTION; MYOCARDITIS; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; REVIEW; RISK ASSESSMENT; SARCOIDOSIS; TISSUE CHARACTERIZATION; TISSUE DIFFERENTIATION; AMYLOIDOSIS; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART PACING; METABOLISM; METHODOLOGY; SUDDEN DEATH;

AMYLOIDOSIS; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHIES; CARDIOMYOPATHY, HYPERTROPHIC; DEATH, SUDDEN, CARDIAC; HEART TRANSPLANTATION; HUMANS; IRON OVERLOAD; MAGNETIC RESONANCE IMAGING; MYOCARDIAL ISCHEMIA; MYOCARDITIS; MYOCARDIUM; RISK ASSESSMENT; SARCOIDOSIS;

EID: 55249112715     PISSN: 15469530     EISSN: 15469549     Source Type: Journal    
DOI: 10.1007/s11897-008-0021-1     Document Type: Review

References (50)

1. Hare JM: The dilated, restrictive, and infiltrative cardiomyopathies. In Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, edn 8. Edited by Libby P. Philadelphia: Saunders Elsevier; 2007:1739-1760.
2. McCrohon JA, Moon JC, Prasad SK, et al.: Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003, 108:54-59.
3. Motoyasu MM, Kurira T, Onishi K, et al.: Correlation between late gadolinium enhancement and diastolic function in hypertrophic cardiomyopathy assessed by magnetic resonance imaging. Circ J 2008, 72:378-383.
4. Maceira AM, Joshi J, Prasad SK, et al.: Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 2005, 111:186-193.
5. Tandri H, Castillo E, Ferreri VA, et al.: Magnetic resonance imaging of arrhythmogenic right ventricular dysplasia: Sensitivity, specificity, and observer variability of fat detection versus functional analysis of the right ventricle. J Am Coll Cardiol 2006, 48:2277-2284.
6. Abdel-Aty H, Simonetti O, Friedrich MG: T2-weighted cardiovascular magnetic resonance imaging. J Magn Reson Imaging 2007, 26:452-459.
7. Hendel RC, Patel MR, Kramer CM, et al.: ACCF/ACR/SCCT/SCMR/ASNC/NASCI/ SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: A report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance
8. Society for Cardiovacular Magnetic Resonance: CMR image acquisition protocols. Available at http://www.scmr.org/documents/ scmr_protocols_2007.pdf. Accessed June 3, 2008.
9. Bellenger NG, Davies LC, Francis JM, et al.: Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2000, 2:271-278.
10. Kwong RY, Chan AK, Brown KA, et al.: Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 2006, 113:2733-2743.
11. Reimer KA, Jennings RB: The "wavefront phenomenon" of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest 1979, 40:633-644.
12. Kim RJ, Wu E, Rafael A, et al.: The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000, 343:1445-1453.
13. Yan AT, Shayne AJ, Brown KA, et al.: Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation 2006, 114:32-39.
14. Schmidt A, Azevedo CF, Cheng A, et al.: Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation 2007, 115:2006-2014.
15. Steendijk P, de Roos A, van der Wall EE, et al.: Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation 2006, 113:969-976.
16. Bardy GH, Lee KL, Mark DB, et al.: Amiodarone or implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005, 352:225-237.
17. Nazarian S, Bluemke DA, Lardo AC, et al.: Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation 2005, 112:2821-2825.
18. Eckart RE, Scoville SL, Campbell CL, et al.: Sudden death in young adults: A 25-year review of autopsies in military recruits. Ann Intern Med 2004, 141:829-834.
19. Drory Y, Turetz Y, Hiss Y, et al.: Sudden unexpected death in persons less than 40 years of age. Am J Cardiol 1991; 68:1388-1392.
20. Eckart RE, Love SS, Atwood JE, et al.: Incidence and follow-up of inflammatory cardiac complications after smallpox vaccination. J Am Coll Cardiol 2004, 44:201-205.
21. Friedrich MG, Strohm O, Schulz-Menger J, et al.: Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation 1998, 97:1802-1809.
22. Mitchell JH, Hadden TB, Wilson JM, et al.: Clinical features and usefulness of cardiac magnetic resonance imaging in assessing myocardial viability and prognosis in Takotsubo cardiomyopathy (transient left ventricular apical ballooning syndrome). Am J Cardiol 2007, 100:296-301.
23. Scholte AJ, Bax JJ, Stokkel MP, et al.: Multimodality imaging to diagnose Takotsubo cardiomyopathy. J Nucl Cardiol 2006, 13:123-126.
24. Vogelsberg H, Mahroldt H, Deluigi CC, et al.: Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis. J Am Coll Cardiol 2008, 51:1022-1030.
25. Selvanayagam JB, Hawkins PN, Paul B, et al.: Evaluation and management of the cardiac amyloidosis. J Am Coll Cardiol 2007, 50:2101-2110.
26. Rahman JE, Helou EF, Gelzer-Bell R, et al.: Noninvasive diagnosis of biopsy-proven cardiac amyloidosis. J Am Coll Cardiol 2004, 43:410-415.
27. Kwong RY, Falk RH: Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 2005, 111:122-124.
28. Mehta D, Lubitz SA, Frankel Z, et al.: Cardiac involvement in patients with sarcoidosis: Diagnostic and prognostic value of outpatient testing. Chest 2008, 133:1426-1435.
29. Schulz-Menger J, Wassmuth R, Abdel-Aty H, et al.: Patterns of myocardial inflammation and scarring in sarcoidosis as assessed by cardiovascular magnetic resonance. Heart 2006, 92:399-400.
30. Tadamura E, Yamamuro M, Kubo S, et al.: Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: Comparison with radionuclide imaging. AJR Am J Roentgenol 2005, 185:110-115.
31. Patel M, Cawley P, Heitner JF, et al.: Detection and prognostic significance of myocardial damage in patients with sarcoidosis using delayed-enhancement cardiac magnetic resonance [abstract]. Circulation 2006, 114(Suppl II):408.
32. Vignaux O, Dhote R, Duboc D, et al.: Detection of myocardial involvement in patients with sarcoidosis applying T2-weighted, contrast-enhanced, and cine magnetic resonance imaging: Initial results of a prospective study. J Comput Assist Tomogr 2002, 26:762-767.
33. Pennell DJ: T2* magnetic resonance and myocardial iron in thalassemia. Ann N Y Acad Sci 2005, 1054:373-378.
34. Westwood M, Anderson LJ, Firmin DN, et al.: A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. J Magn Reson Imaging 2003, 18:33-39.
35. Cheong B, Huber S, Muthupillai R: Evaluation of myocardial iron overload by T2* cardiovascular magnetic resonance imaging. Text Heart Inst J 2005, 3:448-449.
36. Rickers C, Wilke NM, Jerosh-Herold M, et al.: Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation 2005, 112:855-861.
37. Hansen MW, Merchant N: MRI of Pypertrophic cardiomyopathy: part I, MRI appearances. AJR Am J Roentgenol 2007, 189:1335-1343.
38. Amano Y, Takayama M, Sinichiro K, et al.: MR imaging evaluation of regional, remote, and global effects of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy. J Comput Assist Tomogr 2007, 31:600-604.
39. Maron BJ, Maron NS, Lesser JR, et al.: Sudden cardiac arrest in hypertrophic cardiomyopathy in the absence of conventional criteria for high risk status. Am J Cardiol 2008, 101:544-547.
40. McKenna WJ, Thiene G, Nava A, et al.: Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J 1994, 71:215-218.
41. Marcus F, Towbin JA, Zareba W, et al.: Arrhythmogenic right ventricular dysplasia/cardiomyopaDhy (ARVD/C): A multidisciplinary study: design and protocol. Circulation 2003, 107:2975-2978.
42. Bax JJ, Atsma DE, Lamb HJ, et al.: Noninvasive and invasive evaluation of noncompaction cardiomyopathy. J Cardiovasc Magn Reson 2002, 4:353-357.
43. Alsaileek AA, Syed I, Seward JB, et al.: Myocardial fibrosis of left ventricle: Magnetic resonance imaging in noncompaction. J Magn Reson Imaging 2008, 27:621-624.
44. Dodd JD, Holmvang G, Hoffmann U, et al.: Quantification of left ventricular noncompaction and trabecular delayed hyperenhancement with cardiac MRI: Correlation with clinical severity. AJR Am J Roentgenol 2007, 198:974-980.
45. Tan CD, Baldwin WM, Rogriguez ER: Update on cardiac transplantation pathology. Arch Pathol Lab Med 2007, 131:1169-1191.
46. Cooper LT, Baughman KL, Feldman AM, et al.: The role of endomyocardial biopsy in the management of cardiovascular disease. J Am Coll Cardiol 2007, 50:1914-1931.
47. Almenar L, Igual B, Martinez-Dolz L, et al.: Utility of cardiac magnetic resonance imaging for the diagnosis of heart transplant rejection. Transplant Proc 2003, 35:1962-1964.
48. Penno E, Johansson L, Ahlstrom H, et al.: Ultrasmall iron oxide particle contrast agent and MRI can be used to monitor the effect of anti-rejection treatment. Transplantation 2007, 84:374-379.
49. Muehling OM, Wilke NM, Panse P, et al.: Reduced myocardial perfusion reserve and transmural perfusion gradient in heart transplant arteriopathy assessed by magnetic resonance imaging. J Am Coll Cardiol 2003, 42:1054-1060.
50. Marie PY, Angioi M, Carteaux JP, et al.: Detection and prediction of acute heart transplant rejection with the myocardial T2 determination provided by a black-blood magnetic resonance imaging sequence. J Am Coll Cardiol 2001, 37:825-831.